Canada markets close in 2 hours 12 minutes

ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9950+0.1050 (+5.56%)
As of 01:48PM EDT. Market open.

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • P
    Phillip
    CS made an important post yesterday on some of the pending catalysts. The launch into China (once our Hong Kong billionaire CDXC shareholders help finalize Gov't approval) will generate enormous revenues.

    Remember the recent CDXC insider buying from Hong Kong. They know the future profit potential. The revenue potential from future China sales is staggering.

    With the small CDXC float, share price will easily be over $5 and it may happen much sooner than many expect. $7-$8 or higher share price in next 6-9 months. Need to get to $5 first which I expect within next 6 months..

    Excerpt:

    "Pending--

    CBEC launch into China (Sino deal).

    New Premium SKU to support Sino (Sino PR).

    NextGen Tru Niagen (Nagel convo/ Oppenheimer Conference).

    Monetize Patented Next Generation precursors (Key Opinion Leader Webinar)."
  • C
    CS
    In business, as in life, your most important decision is the next one.

    Pending--

    CBEC launch into China (Sino deal).

    New Premium SKU to support Sino (Sino PR).

    NextGen Tru Niagen (Nagel convo/ Oppenheimer Conference).

    Monetize Patented Next Generation precursors (Key Opinion Leader Webinar).

    All TBD.
  • J
    Jeff Manzanita
    The new patent application regarding microcapsulating NR ((NMN, etc.) and more efficiently getting to the cells without deterioration to NAM keeps getting deleted, even without a link the application. Someone doesn't like good news. (5th attempt.)
  • J
    Jeff Manzanita
    Don't sleep on the clinical trial designed by Dr Rudolf Tanzi (co-chair of neurology at Harvard Medical School) that is being conducted at Mass General regarding Long Covid. The updated estimate is that 4.2 million Americans are out of the work force because of Long Covid.
  • R
    Richard
    Time to come back home to CDXC

    Lots of stocks have been decimated and some of them are starting to recover. It looks like the bottom is in on many different companies. I think under $2 at this stage of the game is a no-brainer, so I've been back to a little buying. I don't think this will shoot up overnight, but I think as we get deeper into the year and into early 2023 we'll return to our historic levels in the $4 region. That's more than a double from here. I'm interested. Let's see if the call next week can finally get this back over $2 and onward from there.
  • I
    Ig
    A new clinical trial NCT05483465 listed

    The Effect of NAD Supplementation on Brain Vascular Health in Aging
  • f
    fgmmiami
    ChromaDex to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

    ChromaDex to Report Second Quarter 2022 Financial Results on | CDXC Stock News
    LOS ANGELES ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed. August 10, 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

    https://www.stocktitan.net/news/CDXC/chroma-dex-to-report-second-quarter-2022-financial-results-on-xnisu1ybd77q.html
  • D
    Dufus
    I was buying supplements and now to get on the company who manufactures same. Appears to be cheap? why is this not $3.00 plus?
  • C
    C
    Shares are so difficult to buy... Yet dropping to this level. Expect a 30% up on earning day.
  • w
    walkerbill76
    Well, CCXI just made my year, so I won't be starving due to CDXC.

    Still, would be nice to see NR go mainstream, would probably raise geezer IQ by 5%.
  • w
    walkerbill76
    CDXC files patent on microencapsulation of NR.

    So, wen NR in Boost?
  • s
    stefan_001
    I posted this yesterday but was removed, odd: This looks like a serious problem for Thorne:
    The infomation in your notification and
    amendment was inadequate to demonstrate that your ingredient, "Nicotinamide Riboside
    Hydrogen Malate," is completely dissociated into its constituent ions, Nicotinamide Riboside (NR)
    ion and L-M alate, upon consumption un der the acidic conditions of the gastrointe stinal (GI) tract.
    1
  • r
    r
    I've been on Tru for over 4 years.
    I have not tested positive for Covid. I've been tested 3 times all negative.
    I am wondering what others using Tru have experienced with Covid?
    To say that Tru can prevent viral illness is specious at best; the viral particles will not be blocked from entering mucosal cells, or lung microcappilary cells.
    But symptoms could be mild AND viral titer could be low, possibly too low to detect with a swab (although other tests are more accurate and detect smaller titers).
    I know they've done research on Tru and immune response(s) but am wondering about first hand experience regarding those taking Tru for an extended period and covid positive percent?
  • H
    HotBlonde
    We riding the whale again?
  • b
    bryan
    Shares seem to be on life support here and Fried doesn't seem to give a flying hoot about it.
  • G
    G
    Questions: Rob, who at CDXC was accountable to make the deal with Walmart work? Why did it fail? Why make the deal in the first place if you were not going to support it with a promotional push? Why is the person who was responsible still with CDXC?

    Specifically who is accountable for making the deals with Nestle, Roman, H&H, and Watson’s work?

    Rob, how do you still have a job?
    Or some form of
  • s
    stefan_001
    despite all the dissatisfaction I am optimistic we see a move upward. CDXC is passing on the inflation to the consumer and with the very low churn that may work out well. The stockmarket is somewhat stabilizing. Its waiting for a big player/holder to give this a swing up.
  • E
    Ezra
    Li nailed CELH
  • H
    HotBlonde
    Im getting my whale vibes
  • I
    Ig
    I have an 85 year old relative who got covid while traveling about 12 or 13 days ago.
    He was already taking 300mg/day Niagen but upped to 600.

    I just spoke with him and he sounds terrific. Clear voice and happy. He basically seems totally better in less than 2 weeks.

    I know it’s a sample of just 1. I can’t ever say for sure. But this seems remarkable to me because this person in the past has gotten really whooped by common colds. His sinuses almost always develop secondary infections and in general when he gets sick it’s an ordeal that drags for weeks.